Search
Xtant Medical Holdings Inc
XTNTAdd to Watchlist
0.430USD
-0.005-1.23%
Close 07-31 16:00（ET）Quotes delayed by 15 min
60.20MMarket Cap
32.66P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Xtant Medical Holdings Inc is 8.67, ranking 20 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 1.50, with a high of 1.50 and a low of 1.50.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
1.350
Target Price
+216.75%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Xtant Medical Holdings Inc
XTNT
2
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Xtant Medical Holdings Inc's expected revenue for the next quarter?
Xtant Medical Holdings Inc's expected revenue is 24.88M.
What is Xtant Medical Holdings Inc's price target?
Analysts forecast that Xtant Medical Holdings Inc's price target is USD 1.50, with the highest forecast at USD 1.50 and the lowest forecast at USD 1.50.
What is the analyst rating for Xtant Medical Holdings Inc?
Based on the ratings of Xtant Medical Holdings Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.